00460.HK
Sihuan Pharmaceutical Holdings Group Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.79
+2.61%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
7.1x
Market Cap
HKD 7.36B
MomentumView details →
1D Return
+2.61%
YTD Return
−36.18%
RSI (14)
40.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
7.1x
Market Cap
HKD 7.36B
RSI (14)
40.3
MomentumView details →
1D Return
+2.61%
YTD Return
−36.18%
Similar companies
Latest newsMore news →
Sihuan Pharmaceutical repurchased 10 million shares from the market on August 27, 2026, at an average price of HKD 0.8111 per share, totaling approximately HKD 8.11 million.8d agoSihuan Pharmaceutical reported interim results for the six months ended June 2026, with revenue of RMB 1.1612 billion, up 1.3% year-on-year, and net profit of RMB 224.7 million, up 119% year-on-year, with no dividend declared.10d ago